| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Biddle Warner Weston | Chief Executive Officer, Director | C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE | By: /s/ Marc Grasso, as Attorney-in-Fact | 17 Mar 2026 | 0002034523 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KYTX | Common Stock | Award | +58,000 | $0.000000* | 58,000 | 13 Mar 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KYTX | Stock Option (right to buy) | Award | +350,000 | $0.000000* | 350,000 | 13 Mar 2026 | Common Stock | 350,000 | $8.95 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |
| F2 | 1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |
Exhibit 24 - Power of Attorney